Workplace Weight-Loss showdown: how does wegovy stack up?
NCT ID NCT05579249
Summary
This study compared the effectiveness of the weight loss medication semaglutide (Wegovy) against four other approved drugs for obesity. It involved 500 employed adults with obesity from diverse job backgrounds across three US companies. The main goal was to see which medication helped more people lose a significant amount of weight (10% or more) over one year, while also looking at quality of life and work ability.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nutrition Research Centre
Loma Linda, California, 92354, United States
Conditions
Explore the condition pages connected to this study.